Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. [electronic resource]
Producer: 19931123Description: 2324-8 p. digitalISSN:- 0006-4971
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Transplantation
- Busulfan -- administration & dosage
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- blood
- Thiotepa -- administration & dosage
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.